Nearly 90% of patients who received the combination therapy were still alive after 12 months compared with about 78% of patients who were alive after a year when treated with the older drug Sutent, data showed.
from Hindustan Times - lifestyle https://www.hindustantimes.com/fitness/merck-pfizer-drug-combo-extends-kidney-cancer-survival/story-ivSk4GaZ3aFl9Gudzf3HOL.html>
Subscribe to:
Post Comments
(
Atom
)
0 comments:
Post a Comment